Huntington’s Disease is a genetic neurodegenerative disorder that affects the patient’s normal movement, cognition and behaviour. There are currently no effective marketed treatments for HD. There are significant development programmes for novel and advanced therapies to treat the disease, with a large number of pharmaceutical and biotechnology companies working in this indication. IXICO is proud to be contributing to the work to find a treatment for this disease.
Huntington’s is a terrible disease with a huge unmet need, and patients and their families desperately want treatments that work."